Each dose of reconstituted vaccine (0.2 ml for subcutaneous use or 0.05 ml for in ovo use) contains:
Active substance:
Cell-associated live recombinant turkey herpesvirus (strain HVT/IBD/ILT), expressing the VP2 protein of infectious bursal disease virus and the glycoproteins gD and gI of infectious laryngotracheitis virus: 103.2 – 104.6 PFU1.
1 PFU – plaque forming units.
For the full list of excipients, see section 6.1.